title: Feasibility of measuring the prognostic factors uPA and PAI-1 in core needle biopsy breast cancer specimens.
authors.forename: Christoph
authors.initials: C
authors.lastname: Thomssen
authors.forename: Nadia
authors.initials: N
authors.lastname: Harbeck
authors.forename: Juergen
authors.initials: J
authors.lastname: Dittmer
authors.forename: Shanti R
authors.initials: SR
authors.lastname: Abraha-Spaeth
authors.forename: Nancy
authors.initials: N
authors.lastname: Papendick
authors.forename: Angelo
authors.initials: A
authors.lastname: Paradiso
authors.forename: Bjoern
authors.initials: B
authors.lastname: Lisboa
authors.forename: Fritz
authors.initials: F
authors.lastname: Jaenicke
authors.forename: Manfred
authors.initials: M
authors.lastname: Schmitt
authors.forename: Martina
authors.initials: M
authors.lastname: Vetter
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000737:chemistry*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis*; D011379:Prognosis; D012307:Risk Factors; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D017395:Plasminogen Activator Inhibitor 1; D014568:Urokinase-Type Plasminogen Activator